Mood and anxiety disorders in chronic headache

Headache

Volumn 46, Issue SUPPL. 3, 2006, Pages

  Baskin, Steven M ^a   Lipchik, Gay L ^b   Smitherman, Todd A ^c  

^a New England Institute for Behavioral Medicine   (United States)

^b Saint Vincent Health System   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Cognitive behavioral therapy; Depression; Headache; Migraine; Mood disorders

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; BEHAVIOR THERAPY; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CHRONIC DAILY HEADACHE; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; GENERALIZED ANXIETY DISORDER; HEADACHE; HUMAN; MAJOR DEPRESSION; MIGRAINE; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PANIC; PHOBIA; PRIORITY JOURNAL; REVIEW; TENSION HEADACHE;

ANXIETY DISORDERS; CHRONIC DISEASE; HEADACHE; HUMANS; MOOD DISORDERS;

EID: 33749496654     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00559.x     Document Type: Review

References (104)

1. Feinstein A. The pre-therapeutic classification of comorbidity in chronic disease. J Chronic Dis. 1970;23:455-468.
2. Low NCP, Merikangas KR. The comorbidity of migraine. CNS Spectrums. 2003;8:433-444.
3. Radat F, Swendsen J. Psychiatric comorbidity in migraine: A review. Cephalalgia. 2004;25:165-178.
4. Breslau N, Davis GC. Migraine, major depression, and panic disorder: A prospective epidemiologic study of young adults. Cephalalgia. 1992;12:85-90.
5. Breslau N, Merikangas K, Bowden CL. Comorbidity of migraine and major affective disorders. Neurology. 1994;44(10 suppl 7):S17-S22.
6. Breslau N, Davis GC, Schultz LR, Peterson EL. Migraine and major depression: A longitudinal study. Headache. 1994;34:387-393.
7. Merikangas KR, Stevens DE. Comorbidity ofmigraine and psychiatric disorders. Neurol Clin. 1997;15:115-123.
8. Breslau N. Psychiatric comorbidity in migraine. Cephalalgia. 1998;(suppl 22):56-61.
9. Lipchik GL, Penzien DB. Psychiatric comorbidities in patients with headaches. Semin Pain Med. 2004;2:93-105.
10. Lake AE, Rains JC, Penzien DB, Lipchik GL. Headache and psychiatric comorbidity: Historical context, clinical implications, and research relevance. Headache. 2005;45:493-506.
11. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: An epidemiologic study of young adults. Psychiatry Res. 1991;37:11-23.
12. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Arch Gen Psychiatry. 1990;47:849-853.
13. Swartz KL, Pratt LA, Armenian HK, Lee LC, Eaton WW. Mental disorders and the incidence of migraine headaches in a community sample: Results from the Baltimore Epidemiologic Catchment area follow-up study. Arch Gen Psychiatry. 2000;57:945-950.
14. Breslau N, Davis GC. Migraine, physical health and psychiatric disorder: A prospective epidemiologic study in young adults. J Psychiatr Res. 1993;27:211-221.
15. Breslau N, Schultz LR, Stewart WF, Lipton R, Welch KM. Headache types and panic disorder: Directionality and specificity. Neurology. 2001;56:350-354.
16. Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM. Headache and major depression: Is the association specific to migraine? Neurology. 2000;54:308-313.
17. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression. Neurology. 2003;60:1308-1312.
18. Merikangas KR, Merikangas JR, Angst J. Headache syndromes and psychiatric disorders: Association and familial transmission. J Psychiatr Res. 1993;27:197-210.
19. Verri AP, Proietti Cecchini A, Galli C, Granella F, Sandrini G, Nappi G. Psychiatric comorbidity in chronic daily headache. Cephalalgia. 1998;18(suppl 21): 45-49.
20. Guidetti V, Galli F, Fabrizi P, et al. Headache and psychiatric comorbidity: Clinical aspects and outcome in a 8-year follow-up study. Cephalalgia. 1998;18:455-462.
21. Holroyd KA, Stensland M, Lipchik GL, Hill K, O'Donnell F, Cordingley G. Psychosocial correlates and impact of chronic tension-type headache. Headache. 2000;40:3-16.
22. Saper JR, Lake AE, Tepper SJ. Nefazodone for chronic daily headache prophylaxis: An open-label study. Headache. 2001;41:465-474.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision. Washington, DC: American Psychiatric Association; 2000.
24. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorder in the United States. Results from the National Comorbidity Survey. Arch Gen Psych. 1994;51:8-19.
25. Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. Am J Psychiatry. 1994;151:979-986.
26. Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disorder in the United States: Using a clinical significance criterion to reconcile 2 survey estimates. Arch Gen Psychiatry. 2002;59:115-123.
27. Coyne JC, Fechner-Bates S, Schwenk TL. Prevalence, nature, and comorbidity of depressive disorders in primary care. Gen Hosp Psychiatry. 1994;51:8-19.
28. Hirschfield RMA, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA. 1997;277:333-340.
29. Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999;14:569-580.
30. Mann JJ. The medical management of depression. N Engl J Med. 2005;353:1819-1834.
31. Judd LL. The clinical course of unipolar major depressive disorders. Arch Gen Psychiatry. 1997;54:989-991.
32. Thase ME. Long-term nature of depression. J Clin Psychiatry. 1999;60(suppl 14):3-9.
33. Akiskal HS. Mood disorders: Clinical features. In: Sadock BJ, Sadock VA, eds. Comprehensive Textbook of Psychiatry. Baltimore, MD: Williams and Wilkins; 2000:1138-1377.
34. Bijl RV, Ravelli A. Psychiatric morbidity, service use, and need for care in the general population: Results of the Netherlands Mental Health Survey and Incidence Study. Am J Public Health. 2000;90:602-607.
35. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication. JAMA. 2003;289:3095-3105.
36. Merikangas KR, Zhang H, Avenevoli S, et al. Longitudinal trajectories of depression and anxiety in a prospective community study: The Zurich Cohort Study. Arch Gen Psychiatry. 2003;60:993-1000.
37. Melartin TK, Rytsala HJ, Leskela US, Lestela-Mielonen PS, Sokero TP, Isometsa ET. Current morbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J Clin Psychiatry. 2002;63:126-134.
38. Hirschfield RMA, Vornik LA. Recognition and diagnosis of bipolar disorder. J Clin Psychiatry. 2004;65(suppl 15):5-9.
39. Belmaker RH. Bipolar disorder. N Engl J Med. 2004;351:476-486.
40. Judd LL, Schettler PJ, Akiskal HS, et al. Long-term symptomatic status of bipolar I vs. bipolar II disorder. Int J Neuropsychopharmacol. 2003;6:127-137.
41. Post RM, Denicoff KD, Leverich GS, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH Life Chart Method. J Clin Psychiatry. 2003;64:680-690.
42. Keck PE, McElroy SL, Arnold LM. Bipolar disorder. Med Clin North Am. 2001;85:645-661.
43. Kupfer DJ, Frank E, Grochocinski VJ, Cluss PA, Houck PR, Stapf DA. Demographic and clinical characteristics of individuals in a bipolor disorder case registry. J Clin Psychiatry. 2002;63:120-125.
44. Yatham LN. Diagnosis and management of patients with Bipolar II disorder. J Clin Psychiatry. 2005;66(suppl 1):13-17.
45. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area Study. JAMA. 1990;264:2511-2518.
46. Frye MA, Altshuler LL, McElroy SL, et al. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry. 2003;160:883-889.
47. Freeman MP, Freeman SA, McElroy SL. The comorbidity of bipolar and anxiety disorders: Prevalence, psychobiology, and treatment issues. J Affect Disord. 2002;68:1-23.
48. Kay JH, Altshuler LL, Ventura J, Mintz J. Prevalence of axis II comorbidity in bipolar patients with and without alcohol use disorders. Ann Clin Psychiatry. 1999;11:187-195.
49. Markowitz JS, Weissman MM, Oullette R, et al. Quality of life in panic disorder. Arch Gen Psychiatry. 1989;46:984-992.
50. Kessler R, Stang PE, Wittchen H, et al. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry. 1998;55:801-808.
51. Robins LN, Regier DA, eds. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: Free Press; 1991.
52. Rickles K, Schweizer E. The clinical course and long-term management of generalized anxiety disorder. J Clin Psychopharmacol. 1990;10:1015-1105.
53. Craske MG. Origins of Phobias and Anxiety Disorders: Why More Women Than Men? Oxford, UK: Elsevier; 2003.
54. Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45:1094-1099.
55. Kroenke K, Spitzer RL, Williams JB, et al. Physical symptoms in primary care: Predictors of psychiatric disorders and functional impairment. Arch Fam Med. 1994;3:774-779.
56. Kirmayer LJ, Robbins JM, Dworkind M, et al. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry. 1993;150:734-741.
57. Simon GE, Von Korff M, Piccinelli M, et al. An international study of the relation between somatic symptoms and depression. N Engl J Med. 1999;341:1329-1335.
58. Baskin SM. The headache history. In: Rapoport AM, Sheftell FD, eds. Headache: A Clinicians Guide to Diagnosis, Pathophysiology, and Treatment Strategies. Costa Mesa, CA: PMA; 1993:25-33.
59. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101-2107;
60. Vermeire E, Hearnshaw H, VanRoyer P, Denekens J. Patient adherence to treatment: Three decades of research. A comprehensive review. J Clin Pharm Ther. 2001; 26:331-342.
61. Packard RC, O'Connell P. Medication compliance among headache patients. Headache. 1986.
62. DeBenedittis G, Lorenzetti A. The role of stressful life events in the persistence of primary headache: Major events vs. daily hassles. Pain. 1992; 51:35-42.
63. DeBenedittis G, Lorenzetti A, Pieri A. The role of stressful life events in the onset of chronic primary headache. Pain. 1990; 40:65-76.
64. DeBenedittis G, Lorenzetti A. Minor stressful life events (daily hassles) in chronic primary headache: Relationship with MMPI personality patterns. Headache. 1992;32:330-334.
65. Chabriat H, Danchot J, Michel P, Joire Henry. Precipitating factors of headache: A prospective survey in migraineurs and nonmigraineurs. Headache. 1999;39:335-338.
66. Holm JE, Lokken C, Myers TC. Migraine and stress: A daily examination of temporal relationships in women migraineurs. Headache. 1997;37:553-558.
67. Spierings EL, Schroevers M, Honkoop P, Sorbi M. Presentation of chronic daily headache: A clinical study. Headache. 1998;38:191-196.
68. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache, in a population-based study. Pain. 2003;106:81-89.
69. Siniatchkin M, Riabus M, Hasenbring M. Coping styles of headache sufferers. Cephalalgia. 1999;19:165-173.
70. Leahy RL, Holland SJ. Treatment Plans and Interventions for Depression and Anxiety Disorders. New York: Guilford Press; 2000.
71. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: How far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64:161-174.
72. Oedegaard KJ, Fasmer OB. Is migraine in unipolar depressed patients a bipolar spectrum trait? J Affect Disorders. 2005;84:233-242.
73. Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. Am J Psychiatry. 2000; 157:1873-1875.
74. Maizels M, Smitherman TA, Penzien DB. A review of Screening tools for psychiatric comorbidity in headache patients. Headache. 2006; 46(suppl 3):S98-S109.
75. Antony MM, Rowa K. Evidence-based assessment of anxiety disorders in adults. Psychol Assess. 2005;17:256-266.
76. Clark DM. A cognitive approach to panic. Beh Res Ther. 1986;24:461-464.
77. Keller MB, Hanks DL. Anxiety symptom relief in depression treatment outcomes. J Clin Psychiatry. 1995;56(Suppl 6):22-29.
78. American Psychiatric Association Practice Guideline. Practice guideline for the assessment and treatment of patients with suicidal behaviors. Am J Psychiatry. 2003;160(uppl. 11): S1-60.
79. Prien RF, Kupfer DJ. Continuation drug therapy formajor depressive episodes: How long should it be maintained? Am J Psychiatry. 1986;143:18-23.
80. Griffith J, Razavi M. Psychopharmacological treatment of mood and anxiety disorders in headache patients. Headache2006;46(suppl 3):S133-S141.
81. Beck AT. Cognitive Therapy and the Emotional Disorders. New York: International Universities Press; 1976.
82. Klerman GL, Weissman MM, Rounsaville BJ, et al. Interpersonal Psychotherapy of Depression. New York: Basic Books; 1984.
83. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157(suppl):1-45.
84. Reynolds CF, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years. JAMA. 1999;281:39-45.
85. DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD. Medications versus cognitive behavior therapy for severely depressed outpatients: Meta-analysis of four randomized comparisons. Am J Psychiatry. 1999;156:1007-1013.
86. Pampallona S, Bollini P, Tibaldki G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression: A systematic review. Arch Gen Psychiatry. 2004;61:714-719.
87. Otto MW, Smits J, Reese HE. Combined psychotherapy and pharmacotherapy for mood and anxiety disorder in adults: Review and analysis. Clin Psychol: Sci Pract. 2005;12:72-86.
88. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive-behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342:1462-1470.
89. Lipchik GL, Smitherman T, Penzien DB, Holroyd KA. Basic principles and techniques of behavioral therapy for comorbid psychiatric disorders in headache patients. Headache. 2006;46(suppl 3):S119-S132.
90. Lam DH, Hayward P, Watkins ER, Wright K, Sham P. Relapse prevention in patients with bipolar disorder: Cognitive therapy outcome after 2 years. Am J Psychiatry. 2005;162:324-329.
91. Miklowitz DJ, George EL, Richards JA, et al. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry. 2003;60:904-912.
92. Frank E, Kupfer DJ, Thase ME, et al. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry. 2005;62:996-1004.
93. Pollack MH, Allgulander C, Bandelow B, et al. WCA recommendations for the long-term treatment of panic disorder. CNS Spectr. 2003;8(suppl 1):17-30.
94. Otto MW, Tuby KS, Gould RA et al. An effect-size analysis of the relative efficacy and tolerability of serotonin reuptake inhibitors for panic disorder. Am J Psychiatry. 2001;158:1989-1992.
95. Sheehan DV, Mao CG. Paroxetine treatment of generalized anxiety disorder. Psychopharmacol Bull. 2003;37(suppl 1):64-75.
96. Loder E, Biondi D. General principles of migraine management: The changing role of prevention. Headache. 2005;45(suppl 1):S33-S47.
97. Gould RA, Otto MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev. 1995;15:819-844.
98. Gould RA, Otto MW, Pollack MH, Yap L. Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis. Behav Ther. 1997;28:285-305.
99. Franklin ME, Foa EB. Cognitive behavioral treatments for obsessive compulsive disorder. In: Nathan PE, Gorman JM, eds. A Guide to Treatments That Work (2nd ed.). NewYork: Oxford University Press; 2002:367-386.
100. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ. Behavioral versus pharmacological treatments of obsessive compulsive disorder: A meta-analysis. Psychopharmacology. 1998;136:205-216.
101. Brown TA, Barlow DH. Long-term outcome in cognitive-behavioral treatment of panic disorder: Clinical predictors and alternative strategies for assessment. J Consult Clin Psychol. 1995;63:754-765.
102. Royal Australian and New Zealand College of Psychiatrists. Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia. Aust N Z J Psychiatry. 2003;37:641-656.
103. Cloos JM. The treatment of panic disorder. Curr Opin Psychiatry. 2005;18:45-50.
104. Kaniecki RB. A comorbidity-directed algorithmic approach to the outpatient management of chronic migraine: One-year results of the 2002 Pitt cohort. Headache. 2004;44:520-521.